Pediatric interventional cardiology market seen reaching $3.92 billion by 2030

The pediatric interventional cardiology market is forecast to grow from $2.6 billion in 2025 to $3.92 billion by 2030 as demand rises for minimally invasive heart procedures in children. North America leads the market now, while Asia-Pacific is expected to grow fastest.

Why it matters: - Pediatric interventional cardiology is becoming a bigger part of child heart care as hospitals shift toward minimally invasive procedures. - Market growth reflects rising demand for catheter-based diagnosis and treatment of congenital heart defects. - The expansion matters for providers, device makers and families seeking shorter recovery times and lower-risk alternatives to open-heart surgery.

What happened: - The Business Research Company published its Pediatric Interventional Cardiology Global Market Report 2026, covering market size, trends and forecasts for 2026-2035. - The report puts the market at $2.6 billion in 2025 and $2.81 billion in 2026. - The market is forecast to reach $3.92 billion by 2030. - The report says North America led the market in 2025. - The report says Asia-Pacific is expected to be the fastest-growing region in the coming years. - A free sample of the report is available here. - The full report is available here.

The details: - Pediatric interventional cardiology uses cardiac catheterization to diagnose and treat congenital heart defects in children. - The field offers minimally invasive alternatives to traditional surgery. - The report cites growth from catheter-based interventions, higher detection rates of congenital heart defects, more pediatric cardiac care facilities, better interventional imaging and stronger surgeon expertise. - Future growth drivers include next-generation pediatric cardiac devices, demand for less invasive treatment, more investment in pediatric cardiac infrastructure, advanced imaging and navigation tools, and higher procedural success rates. - The expanding pediatric population is also supporting demand for specialized cardiac care. - The Federal Interagency Forum on Child and Family Statistics reported that the U.S. had about 72.5 million children in 2022. - That total included 22.4 million children ages 0-5, 24.2 million ages 6-11 and 25.8 million ages 12-17. - The U.S. child population is expected to rise to 78.2 million by 2050. - Congenital heart defects are the most common birth anomalies in the U.S., affecting about 1% of newborns, or nearly 40,000 infants annually, according to the Centers for Disease Control and Prevention. - The report notes that interventional cardiology can shorten recovery time, lower infection risk and reduce scarring compared with open-heart surgery. - The market analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspots infographics, key technologies and future trends, plus updated graphics and tables.

Between the lines: - The forecast points to a broader shift in pediatric cardiology toward less invasive care and more device-driven treatment. - Rising diagnosis rates and a larger child population could keep procedure volumes growing even if health systems face capacity constraints. - Regional growth differences suggest the next wave of market expansion may come from countries building out pediatric cardiac infrastructure.

What's next: - The market is projected to keep expanding through 2030 as new devices and imaging tools improve procedure performance. - Asia-Pacific growth could reshape regional competition for pediatric cardiac technologies and services. - Providers and manufacturers will likely focus on infrastructure, training and navigation technologies to capture demand.

The bottom line: - Pediatric interventional cardiology is moving from niche specialty to a faster-growing global market, driven by more children needing heart care and a steady shift toward minimally invasive treatment.